Free Republic

Swansea University researchers have found that a drug commonly used to treat type 2 diabetes can potentially be used in the treatment of autoimmune disorders. Academics have found that the drug, canagliflozin (also known as Invokana), could be used to treat autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus as it targets T-cells, which form an essential component of the immune system. Canagliflozin is a drug that controls blood sugar levels in people with type 2 diabetes, however researchers have found an unexpected role for the drug involving the human immune system. Existing research has reported that targeting...

A new diabetes drug that hit the market in the past week boasts it can drop your glucose levels and flush out "guilty" calories every time you use the bathroom. Experts say that every time the patient urinates, out goes all the unwanted sugar and calories. Doctors say this drug could even help prevent Type 2 diabetes. KVUE's sister station KENS went behind closed doors at the Veterans Affairs hospital to witness clinical trials for other drugs similar to Invokana. Last Friday, the FDA approved Invokana, a drug experts are hailing as a game changer for Type 2 diabetes treatment....